Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

079IC - Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment

Monday, May 21
4:00 PM - 6:00 PM
Location: MCC WEST, 2002

Treatment of renal cell carcinoma has changed with expanding indications for Robotic Partial nephrectomy and inclusion of new FDA approved treatments for advanced RCC. This course will focus on didactic case discussions using video tape analysis of surgical treatment, setup and successful completion of Robotic Partial nephrectomy, complication management and how to optimize outcomes. Urologists are now faced with treatment of advanced RCC with a host of options, from tyrosine kinase inhibitors to mtor inhibitors. This course will cover management of the high risk patient, when to start, what to monitor, and when to switch therapies. The contemporary urologist will need to know how to manage these advanced RCC patients.

Robotic Partial Nephrectomy, Transperitoneal approach: Setup, how to expose the hilum, optimizing resection with early unclamping (30 min) Dr. Lee
Robotic Partial Nephrectomy, Retroperitoneal approach: Setup, patient selection, resection (30min) Dr. Porter
Complications Panel: Tips & Tricks for getting out of trouble, Video analysis
(45min) Dr. Lee, Porter, Castle
Case Discussion: Challenging Management dilemmas (30min)
Dr. Lee, Porter, Castle
Advanced RCC management: Which TKI to use, when to switch to mTor (30 min) Dr. Sartor
Question & Answer (15min Dr. Lee, Gettman, Porter, Castle, Sartor

Learning Objectives:

Benjamin R. Lee

University of Arizona College of Medicine

Dr. Benjamin Lee, Professor & Chief of Urology at the University of Arizona College of Medicine has focused his career on advancing new treatments for renal cell carcinoma as well as calculus disease, while developing new technologies & techniques for Urologic Oncology & Endourology. He is author or co-author of more than 200 manuscripts, book chapters, videos and abstracts. Dr. Lee graduated from Cornell University magna cum laude. He then attended the Johns Hopkins School of Medicine, and continued his training at the James Buchanan Brady Urological Institute at the Johns Hopkins Hospital. He was Assistant Professor at the North Shore Long Island Jewish Medical Center, and then promoted to Associate Professor. He was promoted to Professor with tenure at the Department of Urology at the Tulane University School of Medicine in 2008, and assumed the position of Professor and Chief of Urology at the University of Arizona College of Medicine in 2016. He has published on methods identifying methods of decreasing recurrence of cancer; explanations why the immune system may be activated differently following laparoscopy compared to open surgery, and has developed nanotechnology applications in urologic disease as well as studies into preserving kidney function during laparoscopic & robotic kidney surgery. Dr. Lee’s research has been recognized by awards from the American Urological Association, The Endourological Society and Urology Journal. He was awarded the prestigious Arthur Smith Award in 2008 for his contributions to the discipline of robotics, laparoscopy, and minimally invasive surgery. He was Organizing Secretary of the 31st World Congress of Endourology which was held in New Orleans, LA in 2013.

Presentation(s):

Send Email for Benjamin Lee

A. Oliver Sartor

Tulane Medical School

Dr. Oliver Sartor is an internationally recognized expert in prostate cancer. His medical practice and research have focused on prostate cancer since 1990 when he finished a medical oncology fellowship at the National Cancer Institute (NCI). He has published over 350 articles and book chapters and led multiple national and international clinical trials as either a principal investigator or co-principal investigator. In particular he has helped to lead pivotal trials leading to FDA approval for samarium-153 EDTMP, radium-223, and cabazitaxel. He has lectured widely, and at last count has given invited lectures in 33 countries.

He is currently the Medical Director of the Tulane Cancer Center and serves as the Laborde Professor for Cancer Research at Tulane Medical School with appointments in both the Medicine and Urology Departments.

He has served as the past Chairman of the Department of Defense Prostate Cancer Integration Panel, is currently Editor-in-Chief of the peer-reviewed journal Clinical Genitourinary Cancer, and is the Medical Oncology Chair of the GU committee of NRG. He is also currently a member of the NCI Board of Scientific Counselors (Clinical Sciences and Epidemiology).

Presentation(s):

Send Email for A. Oliver Sartor

Chandru P. Sundaram

Indiana University School of Medicine

Chandru P. Sundaram, MD, is Professor of Urology and Director of the Residency Program and Minimally Invasive Surgery at Indiana University School of Medicine. He was faculty and director of the fellowship in Washington University in St. Louis before moving to Indiana University in 2002. Dr. Sundaram established a fellowship and program in minimally invasive surgery at Indiana University School of Medicine. He has been recognized with teaching awards from both Washington University and Indiana University. He has been a fellow of the Royal College of Surgeons of England since 1989.

Dr. Sundaram is on the Board of Directors of the AUA and the Executive Committee of the Endourological Society. He serves as board member and assistant editor of the Journal of Endourology and Senior Editor of Videourology. Dr. Sundaram has held multiple leadership positions, including president of the AUA's North Central Section, the Indiana Urologic Association and the Society of Urological Robotic Surgeons. In addition, he has been the chairman of the AUA's Laparoscopy, Robotic and New Surgical Technology Committee; has served on the AUA's Education Council. Dr. Sundaram's areas of interest include minimally invasive surgery of the kidney, prostate and adrenal gland. He has authored or co-authored more than 150 articles in peer-reviewed journals, Dr. Sundaram has been an invited faculty at numerous international meetings and institutions around the world.

Presentation(s):

Send Email for Chandru Sundaram


Assets

079IC - Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment